Content available in Spanish only.
Cardiorenal risk in asymptomatic Mexican patients with type 2 diabetes Abstract Objective:
Cardiorenal risk in asymptomatic Mexican patients with type 2 diabetes Abstract Objective:
Juan C. Garnica-Cuéllar 1 
, Rubén Silva-Tinoco 2 , Fabiola Ruiz-Velasco-Hernández 3 , Alberto S. Benítez-Rentería 3 , Sonia C. Juárez-Comboni 4
1 Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Ciudad de México, México; 2 Clínica especializada en el manejo de la Diabetes, Instituto Mexicano del Seguro Social Bienestar Servicios de Salud Pública, Ciudad de México, México; 3 Dirección Médica, AstraZeneca México, Ciudad de México, México; 4 AstraZeneca PLC, Cambridge, Inglaterra
*Correspondence: Juan C. Garnica-Cuéllar, Email not available
Abstract
Objective: To describe cardiorenal risk in Mexican patients with type 2 diabetes (T2D) in primary care.
Method: The iCaReMe Global Registry is a prospective, multicenter, observational project designed to provide real-world information on the care of patients with T2D. It is a cross-sectional analysis of the iCaReMe study in a Mexican cohort. Cardiovascular risk (CVR) was stratified using the European Society of Cardiology 2019 guidelines classification. Renal risk was estimated using the urinary albumin-creatinine ratio and the minimum resource model developed by Gendius to predict a reduced glomerular filtration rate.
Results: A total of 2,761 patients with T2D were included. Elevated and very elevated CVR was identified in 2,663 (96.4%). Albuminuria was present in 658 (24.6%). In a subgroup, structural and/or functional cardiac abnormalities were reported by echocardiography in 499 (38%). Glycated hemoglobin < 7% was present in 31.1%, and 15.3% were on therapy with cardiorenal benefit.
Discussion: A high proportion of patients with T2D in Mexico have a high cardiorenal risk. Health care policies are needed that allow for timely treatment in people at high risk for cardiovascular disease and kidney disease.
Keywords: Type 2 diabetes. Cardiovascular risk. Kidney disease. Primary prevention.
